Effect of culture pH on erythropoietin production by Chinese hamster ovary cells grown in suspension at 32.5 and 37.0°C

2004 ◽  
Vol 89 (3) ◽  
pp. 345-356 ◽  
Author(s):  
Sung Kwan Yoon ◽  
Sang Lim Choi ◽  
Ji Yong Song ◽  
Gyun Min Lee
2007 ◽  
Vol 12 (1) ◽  
pp. 60-72 ◽  
Author(s):  
Yeon Sook Choi ◽  
Doo Young Lee ◽  
Ick Young Kim ◽  
Hong Jin Kim ◽  
Hong Woo Park ◽  
...  

KSBB Journal ◽  
2013 ◽  
Vol 28 (2) ◽  
pp. 86-91 ◽  
Author(s):  
Min-Ho Choi ◽  
Hyun-Myoung Cha ◽  
Sun-Mi Kim ◽  
Yong-Soo Choi ◽  
Dong-Il Kim

Pathology ◽  
1993 ◽  
Vol 25 (3) ◽  
pp. 268-276 ◽  
Author(s):  
Wanda B. Mackinnon ◽  
Marlen Dyne ◽  
Rebecca Hancock ◽  
Carolyn E. Mountford ◽  
Adrienne J. Grant ◽  
...  

Author(s):  
Shazid Md. Sharker ◽  
Md. Atiqur Rahman

Most of clinical approved protein-based drugs or under in clinical trial have a profound impact in the treatment of critical diseases. The mammalian eukaryotic cells culture approaches, particularly the CHO (Chinese Hamster Ovary) cells are mainly used in the biopharmaceutical industry for the mass-production of therapeutic protein. Recent advances in CHO cell bioprocessing to yield recombinant proteins and monoclonal antibodies have enabled the expression of quality protein. The developments of cell lines are possible to upgrade specific productivity. As a result, it holds an interesting area for academic as well as industrial researchers around the world. This review will concentrate on the recent progress of the mammalian CHO cells culture technology and the future scope of further development for the mass-production of protein therapeutics.


Sign in / Sign up

Export Citation Format

Share Document